A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 1)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
52 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hku Eye Centre
Hong Kong, Hong Kong
- Chinese University of Hong Kong Eye Centre
Kowloon, Hong Kong
- Shivam Retina Clinic and Eye Hospital
Surat, Gujarat, India
- Nethra Eye Hospital
Bengaluru, Karnataka, India
- Amrita Institute of Medical Sciences & Research Centre
Kochi, Kerala, India
- Sarakshi Netralaya
Nagpur, Maharashtra, India
- L V Prasad Eye Institute
Bhubaneswar, Odisha, India
- Icare Eye Hospital & Post Graduate Institute
Noida, Uttar Pradesh, India
- Changhua Christian Hospital
Changhua, Changhua, Taiwan
- China Medical University Hospital
Taichung, Taichung, Taiwan
- Taipei Veterans General Hospital
Taipei, Taipei, Taiwan
- Chang Gung Memorial Hospital
Taoyuan, Taoyuan, Taiwan
- Arizona Retina and Vitreous Consultants
Phoenix, Arizona, United States
- Phoenix Retina Associates
Phoenix, Arizona, United States
- Retina Partners of Northwest Arkansas
Springdale, Arkansas, United States
- Retina-Vitreous Associates Medical Group
Beverly Hills, California, United States
- the Retina Partners
Encino, California, United States
- Retinal Consultants Medical Group
Modesto, California, United States
- California Eye Specialists Medical Group
Pasadena, California, United States
- California Eye Specialists Medical Group
Redlands, California, United States
- Retina Consultants of Southern California
Redlands, California, United States
- California Retina Consultants
Santa Maria, California, United States
- Retina Group of New England
Waterford, Connecticut, United States
- Rand Eye Institute
Deerfield Beach, Florida, United States
- Florida Retina Institute
Jacksonville, Florida, United States
- Medeye Associates
Miami, Florida, United States
- Florida Retina Institute
Orlando, Florida, United States
- Retina Care Specialists
Palm Beach Gardens, Florida, United States
- East Florida Eye Institute
Stuart, Florida, United States
- Southeast Retina Center
Augusta, Georgia, United States
- Retina Associates
Elmhurst, Illinois, United States
- University Retina
Lemont, Illinois, United States
- Midwest Eye Institute
Carmel, Indiana, United States
- Cumberland Valley Retina Consultants
Hagerstown, Maryland, United States
- Retina Consultants of Minnesota
Saint Louis Park, Minnesota, United States
- the Retina Institute
St Louis, Missouri, United States
- Retina-Vitreous Surgeons of Central New York
Liverpool, New York, United States
- North Carolina Retina Associates
Wake Forest, North Carolina, United States
- Velocity (meridian) Clinical Research
Cincinnati, Ohio, United States
- Verum Research Llc
Eugene, Oregon, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 19 Oct 2021
- Primary completion
- 10 Apr 2026
- Completion
- 10 Apr 2026
- Last update posted
- 5 May 2026
- Registered enrollment
- 552
- Registry id
- NCT05066997
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.